128KRW
13.91 BKRW
36.31 BKRW
87.63 M
About TELCON RF PHARM
Sector
Industry
CEO
Ji-Hoon Kim
Website
Headquarters
Yongin-si
Employees (FY)
122
Founded
1999
ISIN
KR7200230001
FIGI
BBG007D1S7M7
TELCON RF PHARMACEUTICAL. Inc. engages in the manufacture, development and sale of cable assemblies and medicinal products. It operates through the Radio frequency (RF) business division and Pharmaceutical and bio-pharmaceutical business division. The RF business division provides connectors, cable assemblies and components. The Pharmaceutical and bio-pharmaceutical business division offers algicell solution, gud solution, livamax suspension and other drugs. The company was founded on January 8, 1999 and is headquartered in Yongin-si, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 200230 is 698 KRW — it has increased by 1.16% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange TELCON RF PHARM stocks are traded under the ticker 200230.
200230 stock is 2.19% volatile and has beta coefficient of 1.29. Check out the list of the most volatile stocks — is TELCON RF PHARM there?
Yes, you can track TELCON RF PHARM financials in yearly and quarterly reports right on TradingView.
200230 stock has fallen by 10.51% compared to the previous week, the month change is a 5.16% fall, over the last year TELCON RF PHARM has showed a 42.41% decrease.
200230 net income for the last quarter is 4.07 B KRW, while the quarter before that showed −10.12 B KRW of net income which accounts for 140.26% change. Track more TELCON RF PHARM financial stats to get the full picture.
Today TELCON RF PHARM has the market capitalization of 80.04 B, it has decreased by 1.40% over the last week.
No, 200230 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 200230 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TELCON RF PHARM stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 122.00 employees. See our rating of the largest employees — is TELCON RF PHARM on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TELCON RF PHARM technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TELCON RF PHARM stock shows the sell signal. See more of TELCON RF PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TELCON RF PHARM EBITDA is 5.21 B KRW, and current EBITDA margin is 14.35%. See more stats in TELCON RF PHARM financial statements.